Related Experiment Video
Updated: Jan 23, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Ocular ischaemic complications in giant cell arteritis: CHADS2-score predicts risk of permanent visual impairment
Michael Czihal1, Janina Tschaidse2, Christoph Bernau2
1Division of Vascular Medicine, Medical Clinic and Policlinic IV, University Hospital, Ludwig-Maximilians-University, Munich, Germany. michael.czihal@med.uni-muenchen.de.
Insights
Giant cell arteritis (GCA) patients over 70 are at higher risk for permanent visual loss (PVL). However, constitutional symptoms and axillary artery vasculitis may lower PVL risk. The CHADS2 score helps predict PVL risk in GCA.
Area of Science:
- Rheumatology
- Ophthalmology
- Vascular Medicine
Background:
- Giant cell arteritis (GCA) is a systemic vasculitis often affecting large arteries.
- Permanent visual loss (PVL) is a serious complication of GCA, necessitating identification of risk factors.
- Established scoring systems for ischemic risk assessment are crucial for managing GCA patients.
Purpose of the Study:
- To identify independent risk factors for permanent visual loss (PVL) in patients with giant cell arteritis (GCA).
- To evaluate the role of sonographic findings in temporal, carotid, and axillary arteries in predicting PVL.
- To assess the utility of established ischemia risk scoring systems, like CHADS2 and CHA2DS2-VASc, in GCA-related PVL.
Main Methods:
- Retrospective analysis of 152 consecutive GCA patients diagnosed between 2002 and 2013.
- Data collection included clinical, ophthalmological, laboratory, and arterial ultrasound findings.
- Multivariate logistic regression was used to identify independent risk factors for PVL, with CHADS2 and CHA2DS2-VASc scores calculated.
Main Results:
- PVL occurred in 30.2% of patients, primarily due to anterior ischemic optic neuropathy (91.3%).
- PVL risk significantly increased after age 70.
- Axillary artery vasculitis (OR 0.3) and constitutional symptoms (OR 0.1) were negatively associated with PVL, while a CHADS2 score ≥1 (OR 10.7-25) significantly increased PVL risk.
Conclusions:
- Age is a significant risk factor for PVL in GCA, with risk escalating post-70.
- Presence of constitutional symptoms and axillary artery involvement may indicate a lower risk of PVL.
- The CHADS2 score is a valuable tool for stratifying GCA patients into low and high risk categories for PVL.
Objectives:
To identify independent risk factors for permanent visual loss (PVL) in patients with giant cell arteritis (GCA), with a special focus on sonographic findings of the temporal, carotid and subclavian/axillary arteries, and on established scoring systems of ischaemia risk assessment.
Methods:
Consecutive patients with a diagnosis of GCA between 2002 and 2013 were retrospectively identified from a prospectively maintained database. Data on clinical characteristics including ophthalmological findings, laboratory values, and sonographic findings of the temporal, carotid an axillary arteries were extracted. CHADS2- and CHA2DS2-VASc-score were calculated. Clinical, laboratory and sonographic characteristics of patients with and without PVL were compared. Multiple logistic regression models were calculated to identify variables independently associated with PVL.
Results:
One-hundred-fifty-two patients were included in the analysis. PVL occurred in 30.2% of patients, with anterior ischaemic optic neuropathy as predominant underlying cause (91.3%). The frequency of PVL was strongly dependent on the age at diagnosis, with a significant increase after the age of 70 years. In multivariate analysis, axillary artery vasculitis with an odds ratio (OR) of 0.3 and constitutional symptoms with an OR of 0.1 were negatively associated with PVL. A CHADS2-score of 1 (OR 10.7) or ≥2 (OR 25) was associated with a significantly increased risk of PVL.
Conclusions:
The risk of PVL secondary to GCA increases with age but is lower in patients presenting with constitutional symptoms and/or exhibiting axillary artery involvement. The CHADS2-score may help to discriminate patients with low vs. high risk of PVL.
Related Concept Videos
Introduction to z Scores
z scores...
Introduction to z Scores
z scores...
z Scores and Area Under the Curve
Predicting Molecular Geometry
Relative Risk
Hemodialysis II: Procedure and Complications

